Shengbing Zang

814 total citations
34 papers, 548 citations indexed

About

Shengbing Zang is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Shengbing Zang has authored 34 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Shengbing Zang's work include Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and RNA modifications and cancer (4 papers). Shengbing Zang is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and RNA modifications and cancer (4 papers). Shengbing Zang collaborates with scholars based in China, United States and Netherlands. Shengbing Zang's co-authors include Yun Huang, Yubin Zhou, Aimin Huang, Lijuan Zhou, Zhanjun Li, Jing Ji, Guolin Ma, Xiang Wu, Peng Tan and Youjun Wang and has published in prestigious journals such as Journal of Clinical Investigation, Molecular and Cellular Biology and The Journal of Infectious Diseases.

In The Last Decade

Shengbing Zang

33 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengbing Zang China 11 272 128 107 78 71 34 548
Mario Mauri Italy 12 356 1.3× 85 0.7× 69 0.6× 41 0.5× 41 0.6× 30 587
Jessica Charlet United States 10 543 2.0× 104 0.8× 86 0.8× 60 0.8× 31 0.4× 14 742
Hongjun Jin China 19 465 1.7× 46 0.4× 167 1.6× 123 1.6× 65 0.9× 64 925
Shahram Torkamandi Iran 9 233 0.9× 53 0.4× 49 0.5× 58 0.7× 58 0.8× 21 459
Jeong Heon Lee South Korea 14 246 0.9× 80 0.6× 70 0.7× 42 0.5× 93 1.3× 21 549
Jiřina Procházková Czechia 14 447 1.6× 36 0.3× 140 1.3× 89 1.1× 40 0.6× 22 664
Linhong Sun United States 12 291 1.1× 38 0.3× 122 1.1× 72 0.9× 70 1.0× 18 606
Laura Rosanò Italy 16 335 1.2× 51 0.4× 119 1.1× 43 0.6× 42 0.6× 35 592
Darshini Kuruppu United States 16 287 1.1× 100 0.8× 185 1.7× 43 0.6× 51 0.7× 29 750
Wendy M. Pruitt United States 11 674 2.5× 210 1.6× 126 1.2× 40 0.5× 19 0.3× 12 1.1k

Countries citing papers authored by Shengbing Zang

Since Specialization
Citations

This map shows the geographic impact of Shengbing Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengbing Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengbing Zang more than expected).

Fields of papers citing papers by Shengbing Zang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengbing Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengbing Zang. The network helps show where Shengbing Zang may publish in the future.

Co-authorship network of co-authors of Shengbing Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Shengbing Zang. A scholar is included among the top collaborators of Shengbing Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengbing Zang. Shengbing Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zang, Shengbing, et al.. (2025). Digital Biomarkers for Parkinson Disease: Bibliometric Analysis and a Scoping Review of Deep Learning for Freezing of Gait. Journal of Medical Internet Research. 27. e71560–e71560. 1 indexed citations
2.
Zhang, Xuanye, et al.. (2024). Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine. Cancer Biology and Medicine. 21(9). 1–15. 1 indexed citations
3.
Chen, Kailin, Shiwei He, Sha Gong, et al.. (2024). LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein. Drug Resistance Updates. 76. 101111–101111. 7 indexed citations
4.
Lu, Haizhen, Dong Kuang, Ping Zhou, et al.. (2023). PD-L1 expression in recurrent or metastatic head and neck squamous cell carcinoma in China (EXCEED study): a multicentre retrospective study. Journal of Clinical Pathology. 78(2). 88–95. 2 indexed citations
5.
Zhong, Yujia, Jierong Chen, Shengbing Zang, et al.. (2023). Extranodal NK/T-Cell Lymphoma Predominantly Composed of Anaplastic Cells. The American Journal of Surgical Pathology. 48(2). 174–182. 2 indexed citations
6.
7.
8.
Chao, Xue, Zixian Wang, Shi‐Xun Lu, et al.. (2020). Signet ring cell component in pretreatment biopsy predicts pathological response to preoperative chemoradiotherapy in rectal cancer. International Journal of Clinical Oncology. 25(9). 1653–1662. 2 indexed citations
9.
Lin, Suxia, Xinke Zhang, Xiaoxuan Li, et al.. (2020). Detection of human papillomavirus distinguishes second primary tumors from lung metastases in patients with squamous cell carcinoma of the cervix. Thoracic Cancer. 11(8). 2297–2305. 5 indexed citations
10.
Zeng, Hongxiang, Hailan He, Lei Guo, et al.. (2019). Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies. Cancer Letters. 467. 1–8. 29 indexed citations
11.
Lin, Jie, et al.. (2018). MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial–mesenchymal transition. Clinical and Experimental Medicine. 18(4). 523–533. 30 indexed citations
12.
Zang, Shengbing, Xiaojie Ma, Wenwen Liu, et al.. (2017). PGE 2 synthesis and signaling in malignant transformation and progression of human hepatocellular carcinoma. Human Pathology. 63. 120–127. 24 indexed citations
13.
Su, Hongying, Tao Xu, Xiongfei Huang, et al.. (2017). Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma. Pathology - Research and Practice. 213(12). 1536–1541. 4 indexed citations
14.
Zang, Shengbing, Jia Li, Haiyan Yang, et al.. (2017). Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis. Journal of Clinical Investigation. 127(8). 2998–3012. 69 indexed citations
15.
He, Lian, Yuanwei Zhang, Guolin Ma, et al.. (2015). Near-infrared photoactivatable control of Ca2+ signaling and optogenetic immunomodulation. eLife. 4. 187 indexed citations
16.
Li, Xiaoyan, et al.. (2014). Low expression of activating transcription factor 3 in human hepatocellular carcinoma and its clinicopathological significance. Pathology - Research and Practice. 210(8). 477–481. 11 indexed citations
17.
Xu, Tao, et al.. (2014). Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma. Pathology - Research and Practice. 210(12). 787–792. 10 indexed citations
18.
Zang, Shengbing, Ting‐Yu Lin, Xinji Chen, et al.. (2014). GPKOW is essential for pre-mRNA splicing in vitro and suppresses splicing defect caused by dominant-negative DHX16 mutation in vivo. Bioscience Reports. 34(6). e00163–e00163. 18 indexed citations
19.
Xu, Meifang, Shengbing Zang, Jingfeng Liu, et al.. (2012). [An in vitro study of the relationship between KiSS-1 expression and hepatoma carcinoma cell proliferation, adhesion, and invasion].. PubMed. 20(12). 925–9. 1 indexed citations
20.
Liu, Jingfeng, et al.. (2011). [Role of mPGES-1 in the occurrence, progression, metastasis and invasion of hepatocellular carcinoma].. PubMed. 19(5). 356–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mario Mauri Breakdown of academic impact, for papers by Jessica Charlet Breakdown of academic impact, for papers by Hongjun Jin Breakdown of academic impact, for papers by Shahram Torkamandi Breakdown of academic impact, for papers by Jeong Heon Lee Breakdown of academic impact, for papers by Jiřina Procházková Breakdown of academic impact, for papers by Linhong Sun Breakdown of academic impact, for papers by Laura Rosanò Breakdown of academic impact, for papers by Darshini Kuruppu Breakdown of academic impact, for papers by Wendy M. Pruitt
Rankless by CCL
2026